EIDD-2801 99% Purity Molnupiravir Powder CAS 2349386-89-4 For Sale

Product Description:

Molnupiravir is an antiviral drug that has gained attention for its potential to treat viral infections, particularly in the context of the COVID-19 pandemic. The potential use of Molnupiravir for the treatment of Feline Infectious Peritonitis (FIP) is an area of interest.

FIP is a complex and often fatal viral disease caused by certain strains of feline coronavirus (FCoV). While Molnupiravir has shown promise in inhibiting the replication of RNA viruses, including coronaviruses like SARS-CoV-2, its effectiveness against the specific strains of FCoV responsible for FIP has not been thoroughly investigated in clinical trials.

Technical Parameters:

Function:

1. Antiviral Activity: Molnupiravir works by inhibiting the replication of RNA viruses. It is a prodrug, meaning that it is metabolized in the body into its active form. Once active, Molnupiravir acts as a nucleoside analog, which means it resembles the building blocks of RNA. When a virus replicates, it relies on these building blocks to create new copies of its genetic material. Molnupiravir is incorporated into the viral RNA during replication, leading to the introduction of errors or mutations. These errors can interfere with viral replication, ultimately inhibiting the virus's ability to spread and causing it to become non-functional.

2. Broad-Spectrum Activity: Molnupiravir has shown broad-spectrum activity against a range of RNA viruses, including influenza viruses, coronaviruses (such as SARS-CoV-2), respiratory syncytial virus (RSV), and others. This broad activity makes it potentially useful for treating various viral infections beyond COVID-19.

3. Clinical Use: Molnupiravir has been investigated for the treatment of COVID-19, particularly in patients with mild to moderate symptoms. Clinical trials have suggested that Molnupiravir may reduce the duration of symptoms and decrease the risk of hospitalization in these patients. If approved by regulatory agencies, it could become an essential tool in managing the COVID-19 pandemic.

4. Preventive Potential: There is also interest in exploring the potential of Molnupiravir as a preventive treatment for viral infections. If proven effective, it could be used prophylactically in high-risk populations or during outbreaks to limit the spread of viral diseases.

Packing and Shipping:

1~25kgs packaging: Aluminium bag inside, Carton box outside.

25kgs packaging: Plastic bag inside, Fiber drum outside